Semaglutide
AMAZE 8
Novo Nordisk · Phase 3 · Not yet recruiting · Enrollment 1000
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| NNC0487-0111 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Semaglutide | Obesity + T2D | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Semaglutide
Novo Nordisk · Phase 3 · Not yet recruiting · Enrollment 1000
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| NNC0487-0111 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Semaglutide | Obesity + T2D | n/r | n/r | n/r | n/r |